Cameron R - Search Results

1

Sustained antigen-specific antitumor recall response mediated by gene-modified CD4+ T helper-1 and CD8+ T cells.

Moeller M, Kershaw MH, Cameron R, Westwood JA, Trapani JA, Smyth MJ, Darcy PK. Moeller M, et al. Among authors: cameron r. Cancer Res. 2007 Dec 1;67(23):11428-37. doi: 10.1158/0008-5472.CAN-07-1141. Cancer Res. 2007. PMID: 18056471

2

Gene-engineered T cells as a superior adjuvant therapy for metastatic cancer.

Kershaw MH, Jackson JT, Haynes NM, Teng MW, Moeller M, Hayakawa Y, Street SE, Cameron R, Tanner JE, Trapani JA, Smyth MJ, Darcy PK. Kershaw MH, et al. Among authors: cameron r. J Immunol. 2004 Aug 1;173(3):2143-50. doi: 10.4049/jimmunol.173.3.2143. J Immunol. 2004. PMID: 15265951

3

Synergistic antitumor effects of combination immunotherapy with recombinant interleukin-2 and a recombinant hybrid alpha-interferon in the treatment of established murine hepatic metastases.

Cameron RB, McIntosh JK, Rosenberg SA. Cameron RB, et al. Cancer Res. 1988 Oct 15;48(20):5810-7. Cancer Res. 1988. PMID: 3262413

4

Effect of combined therapy with lymphokine-activated killer cells, interleukin 2 and specific monoclonal antibody on established B16 melanoma lung metastases.

Eisenthal A, Cameron RB, Uppenkamp I, Rosenberg SA. Eisenthal A, et al. Among authors: cameron rb. Cancer Res. 1988 Dec 15;48(24 Pt 1):7140-5. Cancer Res. 1988. PMID: 3263900

5

Biological and antitumor effects of recombinant human macrophage colony-stimulating factor in mice.

Bock SN, Cameron RB, Kragel P, Mulé JJ, Rosenberg SA. Bock SN, et al. Among authors: cameron rb. Cancer Res. 1991 May 15;51(10):2649-54. Cancer Res. 1991. PMID: 2021943

6

Induction of antibody-dependent cellular cytotoxicity in vivo by IFN-alpha and its antitumor efficacy against established B16 melanoma liver metastases when combined with specific anti-B16 monoclonal antibody.

Eisenthal A, Cameron RB, Rosenberg SA. Eisenthal A, et al. Among authors: cameron rb. J Immunol. 1990 Jun 1;144(11):4463-71. J Immunol. 1990. PMID: 2111349

7

Synergistic antitumor activity of tumor-infiltrating lymphocytes, interleukin 2, and local tumor irradiation. Studies on the mechanism of action.

Cameron RB, Spiess PJ, Rosenberg SA. Cameron RB, et al. J Exp Med. 1990 Jan 1;171(1):249-63. doi: 10.1084/jem.171.1.249. J Exp Med. 1990. PMID: 2295878 Free PMC article.

8

Delineation of two defects responsible for T-cell hyporesponsiveness to concanavalin A in MRL congenic mice.

Cameron R, Waterfield JD. Cameron R, et al. Immunology. 1986 Oct;59(2):187-93. Immunology. 1986. PMID: 3095226 Free PMC article.

9

Dynamic Retrieval Augmented Generation of Ontologies using Artificial Intelligence (DRAGON-AI).

Toro S, Anagnostopoulos AV, Bello SM, Blumberg K, Cameron R, Carmody L, Diehl AD, Dooley DM, Duncan WD, Fey P, Gaudet P, Harris NL, Joachimiak MP, Kiani L, Lubiana T, Munoz-Torres MC, O'Neil S, Osumi-Sutherland D, Puig-Barbe A, Reese JT, Reiser L, Robb SM, Ruemping T, Seager J, Sid E, Stefancsik R, Weber M, Wood V, Haendel MA, Mungall CJ. Toro S, et al. Among authors: cameron r. J Biomed Semantics. 2024 Oct 17;15(1):19. doi: 10.1186/s13326-024-00320-3. J Biomed Semantics. 2024. PMID: 39415214 Free PMC article.

10

Light-field tomographic fluorescence lifetime imaging microscopy.

Ma Y, Park J, Huang L, Sen C, Burri S, Bruschini C, Yang X, Cui Q, Cameron RB, Fishbein GA, Gomperts BN, Ozcan A, Charbon E, Gao L. Ma Y, et al. Among authors: cameron rb. Proc Natl Acad Sci U S A. 2024 Oct;121(40):e2402556121. doi: 10.1073/pnas.2402556121. Epub 2024 Sep 25. Proc Natl Acad Sci U S A. 2024. PMID: 39320920

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,075 results

Search Page

Filters